Navigation Links
Identification Of Gene Sequence To Promote Growth Of New Arteries

A Research headed by the vascular surgeon Rajabrata Sarkar, MD, PhD, at the San Francisco VA Medical Center has unraveled the genetic mechanism that helps in the growth of new arteries // . He demonstrated in mice that the MMP2 gene is the key factor for the development of new arteries especially when there is blockage in the femoral (leg) artery.

As a novel approach the team has analyzed and given detailed information on the DNA sequence of the MMP2 gene, which encodes an enzyme believed to promote the growth of new arteries. This can be found in the November 8 issue of the Proceedings of the National Academy of Sciences.

Understanding the development of new arteries is very essential because when there is an insufficient blood flow to the leg, it can lead to gangrene, necessitating leg amputations under worse conditions.

Sarkar and his researchers (University of California, San Francisco) conducted a study in which two sets of mice were taken and human vascular disease was mimicked in the femoral arteries in both the sets, normal mice having the intact gene and the other lacking the MMP2 gene. In about three weeks, the normal mice developed new arteries and the blood flow was restored close to normal levels. In the other set of mice that lacked MMP2 gene, new arteries failed to grow and 40% of these lost a part of their leg as a result of gangrene. This shows that the gene is vital for the growth of new arteries when there is blockage.

The research team also studied accurately those areas of the MMP2 gene that were activated in skeletal muscles when there was a decrease in the blood flow. The transgenic mice created, by David Lovett, provided a representation of the arterial blockage.

The beta galactosidase gene marker was incorporated into the transgenic mice, which turns tissues blue. Different strains of the mice had different fragments of the MMP2 gene linked to the marker gene. When there is an arterial blocka ge in the strain of mice with the specific gene sequence, the leg muscles turn blue. Hence this paved way for the researchers to specifically spot new areas within the MMP2 gene and other adjuvant molecules that are necessary for the expression of the gene during decreased blood flow.

As it is a fundamental approach to understand the pathway of the gene involved in the growth of arteries, further research has to be done to understand the various conditions like cigarette smoking, high cholesterol, diabetes, and hypertension in relation with vascular diseases according to the researchers.

The research teams intend to study the same genetic mechanisms in humans, with the tissue samples taken from patients during surgery. It is hoped that this research would eventually pave way for the development of novel treatment modalities towards ‘curing’ patients with arterial blockage.


'"/>




Related medicine news :

1. New Gene Identification Help Asthma Treatments
2. The Use of Radio Frequency Identification ( RFID) to tackle the growing menace of counterfeit drugs
3. Identification of gene
4. Protein Markers for Identification of Brain Tumor
5. Colour Identification Lies Wholly On the Left Hemisphere of the Brain.
6. Novel Technique For Identification And Treatment Of Neurodegenerative Diseases
7. Combined Imaging Approach may Provide Better Identification of Difficult-to-diagnose Brain Clots
8. Dog (Mans best friend) Genome Sequenced
9. New Technique Enables Better Nursing Of Robin Sequence Infants
10. Human Complexity Can Be Attributed To Regulatory Sequence
11. NHGRI Aims To Sequence Primate Genomes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids ... sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited ... all ages; it is a non-competitive, non-timed event, which is all about having fun ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
Breaking Medicine Technology: